E-LIB Suche - Ergebnisse für: Yee, Ka Lai

1

Characterization of ascending dose canine telemetry model s..:

Chaves, Alysia A. ; Ferraro, Jude W. ; Yu, Jing...
Journal of Pharmacological and Toxicological Methods. 128 (2024) - p. 107525 , 2024

Link: https://doi.org/10.1016/..

2

Dealing With Variable Drug Exposure Due to Variable Hepatic..:

Rostami‐Hodjegan, Amin ; Al‐Majdoub, Zubida M. ; von Grabowiecki, Yannick...
Clinical Pharmacology & Therapeutics. , 2024

Link: https://doi.org/10.1002/..

3

Potential serotype-specific effectiveness against IPD of pn..:

Ryman, Josiah ; Sachs, Jeffrey R. ; Banniettis, Natalie...
Expert Review of Vaccines. 23 (2024) 1 - p. 467-473 , 2024

Link: https://doi.org/10.1080/..

4

Predicted serotype-specific effectiveness of pneumococcal c..:

Ryman, Josiah ; Sachs, Jeffrey R. ; Yee, Ka Lai...
Expert Review of Vaccines. 23 (2023) 1 - p. 60-68 , 2023

Link: https://doi.org/10.1080/..

5

Predicting effectiveness of the V114 vaccine against invasi..:

Ryman, Josiah ; Weaver, Jessica ; Yee, Ka Lai.
Expert Review of Vaccines. 21 (2022) 10 - p. 1515-1521 , 2022

Link: https://doi.org/10.1080/..

6

Predicting vaccine effectiveness against invasive pneumococ..:

Ryman, Josiah ; Weaver, Jessica ; Hu, Tianyan...
npj Vaccines. 7 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

7

PBPK-PD modeling for the preclinical development and clinic..:

Bloomingdale, Peter ; Bumbaca-Yadav, Daniela ; Sugam, Jonathan...
Frontiers in Pharmacology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

8

Coproporphyrin I as an Endogenous Biomarker to Detect Reduc..:

Takita, Hiroyuki ; Scotcher, Daniel ; Chu, Xiaoyan...
Clinical Pharmacology & Therapeutics. 112 (2022) 3 - p. 615-626 , 2022

Link: https://doi.org/10.1002/..

9

Physiologically Based Pharmacokinetic Modeling of Doravirin..:

Yee, Ka Lai ; Cabalu, Tamara D. ; Kuo, Yuhsin...
The Journal of Clinical Pharmacology. 61 (2020) 3 - p. 394-405 , 2020

Link: https://doi.org/10.1002/..

10

A Microdose Cocktail to Evaluate Drug Interactions in Patie..:

Tatosian, Daniel A. ; Yee, Ka Lai ; Zhang, Zufei...
Clinical Pharmacology & Therapeutics. 109 (2020) 2 - p. 403-415 , 2020

Link: https://doi.org/10.1002/..

11

A time-to-event analysis of the exposure–response relations..:

Yee, Ka Lai ; Kleijn, Huub Jan ; Zajic, Stefan..
Journal of Pharmacokinetics and Pharmacodynamics. 47 (2020) 2 - p. 121-130 , 2020

Link: https://doi.org/10.1007/..

12

P210 - Development of a physiologially based pharmacokineti..:

Cabalu, Tamara ; Yee, Ka Lai ; Kuo, Yuhsin...
Drug Metabolism and Pharmacokinetics. 35 (2020) 1 - p. S86 , 2020

Link: https://doi.org/10.1016/..

13

Comparative Bioavailability of Oral Granule Formulations of..:

Yee, Ka Lai ; DiBenedetto, Adrienne ; Fan, Li...
AAPS PharmSciTech. 21 (2020) 3 - p. , 2020

Link: https://doi.org/10.1208/..

14

Population Pharmacokinetic and Pharmacodynamic Analysis To ..:

Vaddady, Pavan ; Kandala, Bhargava ; Yee, Ka Lai
Antimicrobial Agents and Chemotherapy. 64 (2020) 11 - p. , 2020

Link: https://doi.org/10.1128/..

15

Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside..:

Khalilieh, Sauzanne ; Yee, Ka Lai ; Sanchez, Rosa...
Clinical Drug Investigation. 40 (2020) 10 - p. 927-946 , 2020

Link: https://doi.org/10.1007/..